MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 5.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,348 | +0.2% | 272 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,340 | +0.1% | 272 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,337 | +7.2% | 272 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,112 | +211.2% | 272 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $1,000 | -50.0% | 272 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $2,000 | 0.0% | 272 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | -99.8% | 272 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $1,062,000 | – | 272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 1,894,013 | $23,353,180 | 21.09% |
| Newtyn Management, LLC | 1,873,694 | $23,102,647 | 5.70% |
| Sio Capital Management, LLC | 288,466 | $3,556,786 | 1.10% |
| Madison Avenue Partners, LP | 553,085 | $6,819,538 | 0.97% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 209,739 | $2,586 | 0.95% |
| Indaba Capital Management, L.P. | 136,802 | $1,686,769 | 0.50% |
| Sepio Capital, LP | 306,680 | $3,781,364 | 0.33% |
| Yakira Capital Management, Inc. | 54,118 | $667,275 | 0.18% |
| Centiva Capital, LP | 187,803 | $2,315,611 | 0.05% |
| FIFTH LANE CAPITAL, LP | 10,929 | $134,427 | 0.05% |